professional documents
home
Upload
docsters
Upload

search results


NDA FDA MEDICAL AND STATISTICAL ODAC REPORT Drug

FDADocs 5/9/2008 | 0 (0) | 84 | 1 | 0 | English

sNDA 20-726 FDA MEDICAL AND STATISTICAL ODAC REPORTDrug Name: Femara?? Letrozole tablets Applicant: Novartis Date Submitted: July 11, 2000 Date Received: July 12, 2000 Date of Review: November  ... more>>

Drug and Device Product Approvals FDA Drug and Device Product Approvals

FDADocs 5/9/2008 | 0 (0) | 47 | 1 | 0 | English

FDA DRUG AND DEVICE PRODUCT APPROVALSVolume 17 (1) January 1994Center for Drug Evaluation and Research *George R. Scott (301) 443-3910 Center for Biologics Evaluation and Research Joseph  ... more>>

Division of Drug Marketing Advertising and Communications FDA Pharmacy Student Experiential Program

FDADocs 5/12/2008 | 0 (0) | 21 | 1 | 0 | English

The Division of Drug Marketing, Advertising, and Communications (DDMAC) protects the public health by assuring prescription drug information is truthful, balanced, and accurately c...  ... more>>

FDA in the International Community CDER Forum for International Drug Regulatory Authorities

FDADocs 5/9/2008 | 0 (0) | 16 | 1 | 0 | English

CDER Forum for International Drug Regulatory AuthoritiesApril 16 ??? 20, 2007CDER???s International ProgramJustina A. Molzon, M.S. Pharm., J.D. Associate Director for Inter...  ... more>>

Embryonic Stem Cell based Therapies US FDA Regulatory Expectations

FDADocs 5/5/2008 | 0 (0) | 19 | 1 | 0 | English

Embryonic Stem Cell-based Therapies: US-FDA Regulatory ExpectationsDonald W. Fink, Jr., Ph.D.Phone: (301) 827-5153 E-Mail: donald.fink@fda.hhs.govOffice of Cellular, Tissue and Gene Therapies  ... more>>

End Points and United States Food and Drug Administration Approval of Oncology Drugs Cancer Drug Approval Endpoints

FDADocs 5/9/2008 | 0 (0) | 30 | 1 | 0 | English

13 years. Materials and Methods: The FDA granted marketing approval to 71 oncology drug applications...End Points and United States Food and Drug Administration Approval of Oncology DrugsBy John R  ... more>>

Hospital Acquired Pneumonia HAP IDSA PhRma FDA Working Group Meeting

FDADocs 5/12/2008 | 0 (0) | 36 | 1 | 0 | English

Hospital Acquired Pneumonia (HAP) Joint FDA/IDSA/PhRMA WorkshopSary Beidas, MD Medical Officer CDER/DSPIDPNovember 20, 2002Definition of HAP (& Diagnosis):???Clinical: Temp, WBC, Sputum  ... more>>

FCG FDA SPL Demo Conference Meeting and Workshop Presentations by CDER Staff

FDADocs 5/12/2008 | 0 (0) | 26 | 1 | 0 | English

SPL DemonstrationJune 4, 2004Who is FCG?Who is FCG?A leading provider of consulting, technology, applied research and outsourcing services to the life sciences and he...  ... more>>

SUMMARY BASIS FOR APPROVAL Reference Numbers Biological Product

FDADocs 5/5/2008 | 0 (0) | 32 | 1 | 0 | English

SUMMARY BASIS FOR APPROVALReference Numbers: Biological Product Name: Manufacturer: 87-0508 and 87-0509 Fibrin Sealant 6sterreichisches Institut Fiir Haemoderivate Subsidiary of IMMUNO AG (QIH  ... more>>

FDA Labeling Supplement Approval Letter Historical Information

FDADocs 5/9/2008 | 0 (0) | 57 | 0 | 0 | English

DEPARTMENT OF HEALTH & HUMAN SERVICESPublic Health ServiceFood and Drug Administration Rockville, MD 20857NDA 18-662/S046Hoffman-La Roche Inc. Attention: Joanna Wau...  ... more>>

FDA Labeling Supplement Approval Letter

GovernmentDocs 5/5/2008 | 0 (0) | 59 | 0 | 0 | English

NDA 20-895/S-003Pfizer Inc Attention: Rita Wittich Director, Regulatory Affairs 235 East 42nd Street New York, NY 10017Dear Ms. Wittich: Please refer to your supplemental n...  ... more>>

FDA and Industry Actions on Premarket Approval Applications PMAs Effect on FDA Review Clock and Performance Assessment Guidance for Industry and FDA Staff

GovernmentDocs 5/4/2008 | 0 (0) | 68 | 0 | 0 | English

Guidance for Industry and FDA Staff FDA and Industry Actions on Premarket Approval Applications (PMAs): Effect on FDA Review Clock and Performance AssessmentDocument Issued on: October 8, 2003For  ... more>>

Guidance for Industry and FDA Staff Premarket Approval Application Modular Review

GovernmentDocs 5/4/2008 | 0 (0) | 156 | 0 | 0 | English

Guidance for Industry and FDA Staff Premarket Approval Application Modular ReviewDocument issued... Wolanski (CDRH) at 301-594-2186 or by e- mail at nlw@cdrh.fda.gov. For questions rega rding the  ... more>>


   
  results / page   15/25/50 Page: 4 of 33 << prev 1234567...33 next >>